A recent publication at the KIR addressed the use of artificial intelligence in nephrology. The authors designed an algorithm aimed at early intensification of rituximab regimen in patients at high estimated risk of underdosing to increase the likelihood of remission. They predict the risk of underdosing based on patientsβ characteristics.
Check the full publication at https://www.kireports.org/article/S2468-0249(23)01563-2/fulltext
or watch the ππ¦π‘ π©ππππ’ πππ¦π§π₯πππ§ π¦ππ₯πππ¦: Optimization of Rituximab Therapy in Adult patients with PLA2R1-associated Membranous Nephropathy with Artificial Intelligence at
https://x.com/isnkidneycare/status/1759457828954132542?s=46&t=ZrHBe4wvXNR23AIl4lTaPQ
Do you have other insights on how AI can help nephrology? Post here...
Comments